A randomized trial comparing axillary dissection to no axillary dissection in older patients with T1N0 breast cancer: Results after 5 years of follow-up

Annals of Surgery

Volumn 242, Issue 1, 2005, Pages 1-6

  Martelli, Gabriele ^a   Boracchi, Patrizia ^a   De Palo, Michaela ^a   Pilotti, Silvana ^a   Oriana, Saro ^a   Zucali, Roberto ^a   Daidone, Maria Grazia ^a   De Palo, Giuseppe ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

TAMOXIFEN;

AGED; AGING; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HOT FLUSH; HUMAN; HUMAN TISSUE; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; NAUSEA; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SEGMENTAL MASTECTOMY; SENTINEL LYMPH NODE BIOPSY; THROMBOEMBOLISM;

AGE FACTORS; AGED; AGED, 80 AND OVER; AXILLA; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; CONFIDENCE INTERVALS; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; MASTECTOMY, SEGMENTAL; NEOPLASM STAGING; POISSON DISTRIBUTION; PROGNOSIS; PROSPECTIVE STUDIES; REFERENCE VALUES; RISK ASSESSMENT; SURVIVAL ANALYSIS; TAMOXIFEN; TREATMENT OUTCOME;

EID: 21444457854     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.sla.0000167759.15670.14     Document Type: Article

References (29)

1. Halsted WS. The results of radical operations for the cure of cancer of the breast. Ann Surg. 1907;46:1-5.
2. Fisher B, Redmond C, Fisher ER, et al. Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. N Engl J Med. 1985;312:674-681.
3. Gervasoni JE Jr, Taneja C, Chung MA, et al. Axillary dissection in the context of the biology of lymph node metastases. Am J Surg. 2000;180: 278-283.
4. Veronesi U, Paganelli G, Viale G, et al. Sentinel lymph node biopsy and axillary dissection in breast cancer: results in a large series. J Natl Cancer Inst. 1999;91:368-373.
5. Tabar L, Smith RA, Vitak B, et al. Mammographic screening: a key factor in the control of breast cancer. Cancer J. 2003;9:15-27.
6. Menard S, Bufalino R, Rilke F, et al. Prognosis based on primary breast carcinoma instead of pathological nodal status. Br J Cancer. 1994;70: 709-712.
7. De Laurentiis M, Gallo C, De Placido S, et al. A predictive index of axillary nodal involvement in operable breast cancer. Br J Cancer. 1996;73:1241-1247.
8. Ravdin PM, De Laurentiis M, Vendely T, et al. Prediction of axillary lymph node status in breast cancer patients by use of prognostic indicators. J Natl Cancer Inst. 1994;86:1171-1175.
9. Martelli G, Miceli R, De Palo G, et al. Is axillary dissection necessary in elderly patients with breast carcinoma who have a clinically uninvolved axilla? Cancer. 2003;97:1156-1161.
10. Elston CW, Ellis IO. Pathological prognostic factors in breast cancer: I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology. 1991;19:403-410.
11. Cytel Software Corporation. StatXact5-User Manual, Release 5. 0.2, Part III: Inference for Categorical Data. 2001:431-445.
12. Marubini E, Valsecchi MG. Analysing Survival Data From Clinical Trials and Observational Studies. Chichester, UK: John Wiley & Sons, 1995.
13. Gray RJ. A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat. 1988;16:1140-1154.
14. Fisher B, Jeong JH, Anderson S, et al. Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. N Engl J Med. 2002;347:567-575.
15. Zurrida S, Orecchia R, Galimberti V, et al. Axillary radiotherapy instead of axillary dissection: a randomized trial. Ann Surg Oncol. 2002;9:156-160.
16. Wong JS, Recht A, Beard CJ, et al. Treatment outcome after tangential radiation therapy without axillary dissection in patients with early-stage breast cancer and clinically-negative axillary nodes. Int J Radiat Oncol Biol Phys. 1997;39:915-920.
17. Kuznetsova M, Graybill JC, Zusag TW, et al. Omission of axillary lymph node dissection in early-stage breast cancer: effect on treatment outcome. Radiology. 1995;197:507-510.
18. Aristei C, Chionne F, Marsella AR, et al. Evaluation of level I and II axillary nodes included in the standard breast tangential field and calculation of the administered dose: results of a prospective study. Int J Radiat Oncol Biol Phys. 2001;51:69-73.
19. Martelli G, De Palo G, Rossi N, et al. Long-term follow-up of elderly patients with operable breast cancer treated with surgery without axillary dissection plus adjuvant tamoxifen. Br J Cancer. 1995;72:1251-1255.
20. Cummings FJ, Gray R, Tormey DC, et al. Adjuvant tamoxifen versus placebo in elderly women with node-positive breast cancer: long-term follow-up and causes of death. J Clin Oncol. 1993;11:29-35.
21. Fisher B, Costantino J, Redmond C, et al. A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive rumors. N Engl J Med. 1989;320:479-484.
22. Saphner T, Tormey DC, Gray R. Venous and arterial thrombosis in patients who received adjuvant therapy for breast cancer. J Clin Oncol. 1991;9:286-294.
23. Fisher B, Costantino JP, Redmond CK, et al. Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14. J Natl Cancer Inst. 1994;86:527-537.
24. Baum M, Buzdar A, Cuzick J, et al. Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of post-menopausal women with early-stage breast cancer: results of the ATAC trial efficacy and safety update analyses. Cancer. 2003;98:1802-1810.
25. Veronesi U, Paganelli G, Viale G, et al. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med. 2003;349:546-553.
26. Veronesi U, Marubini E, Mariani L, et al. Radiotherapy after breast-conserving surgery in small breast carcinoma: long-term results of a randomized trial. Ann Oncol. 2001;12:997-1003.
27. Gruenberger T, Gorlitzer M, Soliman T, et al. It is possible to omit postoperative irradiation in a highly selected group of elderly breast cancer patients. Breast Cancer Res Treat. 1998;50:37-46.
28. Hughes KS, Schnaper L, Berry D, et al. Comparison of lumpectomy plus tamoxifen with and without radiotherapy (RT) in women 70 years of age or older who have clinical stage I, estrogen receptor positive (ER+) breast carcinoma [Abstract]. Proc Am Soc Clin Oncol. 2001;20:93.
29. Fyles A, McCready D, Manchul L, et al. Preliminary results of a randomized study of tamoxifen +/- breast irradiation in T1/2 N0 disease in women over 50 years of age [Abstract]. Proc Am Soc Clin Oncol. 2001;20:92.